| Date Filed | Type | Description |
| 10/04/2023 |
4
| Boyer David W. (Chief Corp. Affairs Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,437 shares
@ $112.68, valued at
$161.9k
|
|
| 08/23/2023 |
4
| ROBERTS EIRY (Chief Medical Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 3,198 shares
@ $107.3758, valued at
$343.4k
|
|
| 08/23/2023 |
4
| Onyia Jude (Chief Scientific Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 3,198 shares
@ $107.3696, valued at
$343.4k
|
|
| 08/23/2023 |
4
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 2,132 shares
@ $107.388, valued at
$229k
|
|
| 08/23/2023 |
4
| GORMAN KEVIN CHARLES (CEO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 9,328 shares
@ $107.3988, valued at
$1M
|
|
| 08/23/2023 |
4
| Gano Kyle (Chief Business Development Off) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 2,132 shares
@ $107.4075, valued at
$229k
|
|
| 08/23/2023 |
4
| Delaet Ingrid (Chief Regulatory Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,404 shares
@ $107.4219, valued at
$150.8k
|
|
| 08/23/2023 |
4
| Cooke Julie (Chief Human Resources Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 2,132 shares
@ $107.4065, valued at
$229k
|
|
| 08/23/2023 |
4
| Boyer David W. (Chief Corp. Affairs Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,600 shares
@ $107.4138, valued at
$171.9k
|
|
| 08/23/2023 |
4
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,600 shares
@ $107.3975, valued at
$171.8k
|
|
| 08/23/2023 |
4
| ABERNETHY MATT (CFO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 2,132 shares
@ $107.3914, valued at
$229k
|
|
| 07/13/2023 |
4
| POON CHRISTINE A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 16,375 options to buy
@ $98.19, valued at
$1.6M
|
|
| 07/13/2023 |
3
| POON CHRISTINE A (Director) has filed a Form 3 on NEUROCRINE BIOSCIENCES INC |
| 05/19/2023 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 4,199 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| Sharp Shalini (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 4,290 options to buy
@ $95.27, valued at
$408.7k
Granted 2,100 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| RASTETTER WILLIAM H (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 8,579 options to buy
@ $95.27, valued at
$817.3k
|
|
| 05/19/2023 |
4
| POPS RICHARD F (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 4,199 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| Norwalk Leslie V (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 4,290 options to buy
@ $95.27, valued at
$408.7k
Granted 2,100 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| MORROW GEORGE J (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 4,199 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| Mercier Johanna (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 4,290 options to buy
@ $95.27, valued at
$408.7k
Granted 2,100 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| LYONS GARY A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 4,290 options to buy
@ $95.27, valued at
$408.7k
Granted 2,100 restricted stock units
@ $0 |
|
| 05/11/2023 |
4/A
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC |
| 05/11/2023 |
4/A
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC |
| 05/11/2023 |
4/A
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC |
| 05/03/2023 |
4
| RASTETTER WILLIAM H (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 4,300 shares
@ $101.4268, valued at
$436.1k
Exercised 7,625 options to buy
@ $12.71, valued at
$96.9k
|
|
| 05/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/27/2023 |
4
| Cooke Julie (Chief Human Resources Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 100 shares
@ $103.82, valued at
$10.4k
|
|
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2023 |
4
| NEUROCRINE BIOSCIENCES INC (10% Owner) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Bought 4,395,588 shares
@ $8.88, valued at
$39M
|
|
| 02/08/2023 |
4
| Cooke Julie (Chief Human Resources Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 640 shares
@ $105.4659, valued at
$67.5k
Sold 575 shares
@ $104.28, valued at
$60k
Sold 913 shares
@ $102.2457, valued at
$93.4k
Sold 12,801 shares
@ $102.4073, valued at
$1.3M
Sold 822 shares
@ $104.03, valued at
$85.5k
Sold 700 shares
@ $103.9514, valued at
$72.8k
Sold 628 shares
@ $103.69, valued at
$65.1k
|
|
| 02/08/2023 |
4
| ROBERTS EIRY (Chief Medical Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,121 shares
@ $105.8004, valued at
$118.6k
Sold 1,623 shares
@ $102.35, valued at
$166.1k
Sold 12,801 shares
@ $102.4075, valued at
$1.3M
Sold 980 shares
@ $104.1551, valued at
$102.1k
|
|
|